Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, and survival rates have significantly improved with risk-adapted chemotherapy protocols that include asparaginase as a key component [1]. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.